Cargando…
The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay
Breast cancer is the most commonly diagnosed cancer in women, with 10% of disease attributed to hereditary factors. Although BRCA1 and BRCA2 account for a high percentage of hereditary cases, there are more than 25 susceptibility genes that differentially impact the risk for breast cancer. Tradition...
Autores principales: | Chong, Hansook Kim, Wang, Tao, Lu, Hsiao-Mei, Seidler, Sara, Lu, Hong, Keiles, Steven, Chao, Elizabeth C., Stuenkel, A. J., Li, Xiang, Elliott, Aaron M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022661/ https://www.ncbi.nlm.nih.gov/pubmed/24830819 http://dx.doi.org/10.1371/journal.pone.0097408 |
Ejemplares similares
-
Correction: The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay
Publicado: (2014) -
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014) -
DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes
por: Richardson, Marcy E., et al.
Publicado: (2018) -
Correction: DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes
por: Richardson, Marcy E., et al.
Publicado: (2018) -
Comparison of fast-track diagnostics respiratory pathogens multiplex real-time RT-PCR assay with in-house singleplex assays for comprehensive detection of human respiratory viruses()
por: Sakthivel, Senthilkumar K., et al.
Publicado: (2012)